Dental Practice Valuation Multiples in New Jersey (2026)

New Jersey dental practice valuation multiples benchmarks for 2026. Operator-focused analysis + free calculator.

Run the two valuation shortcuts every dental broker quotes against the average American general practice and they land $272,401 apart. Peak Business Valuation pegs dental comparable transactions at roughly 0.65x revenue and about 1.63x to 1.70x seller's discretionary earnings. Apply the revenue rule to the ADA Health Policy Institute's 2025 average general-practice gross billings of $965,660 and you get $627,679. Apply the earnings rule to the same institute's 2025 average net income of $215,320 and you get $355,278. Same practice, two standard methods, a $272,401 gap.

Here's our position, and plenty of New Jersey owners will hate it: most single-doctor general practices in this state have no EBITDA worth multiplying, which means the 5x-to-12x bands circulating in every study club and broker deck describe a business you don't own. EBITDA is whatever's left after you hire someone to be you. Most solo owners have never met that number, and the first time they do is in a buyer's spreadsheet, three weeks before closing, when the offer drops by a third.

Why 7x Belongs to Somebody Else's Practice

Dental Transitions lays out the 2026 bands cleanly: practices with under $1 million of EBITDA trade at 5x to 7x, $1 million to $3 million at 7x to 9x, $3 million to $5 million at 9x to 11x, and $5 million-plus platforms at 10x to 12x and up. Institutional buyers pay 20% to 40% premiums over doctor-to-doctor deals. Every one of those numbers is real. The problem is which end of the first band you actually sit in.

Look at the arithmetic required to clear $1 million of EBITDA. EBITDA is earnings after you pay market-rate compensation to the dentists producing the work, so on a 38% flow-through you'd need roughly $2.6 million in collections to get there. That's a three-to-four-doctor group with a hygiene department that runs like a second business. A solo owner in Somerset County collecting $950,000 is not in a multiple conversation with that practice. They're in a different asset class, and the band they belong to is the bottom of 5x applied to a very small base.

The 20% to 40% institutional premium follows the same logic. A DSO pays a premium for a platform: multiple doctors, transferable systems, a de novo pipeline, a management layer that survives the founder's exit. It does not pay a premium for a one-doctor office it will treat as a tuck-in and staff with an associate at 30% of production. Owners routinely hear "DSOs are paying 8x" and convert that into a personal expectation. They are paying 8x, to somebody else.

$950,000 in Collections, Two Honest Numbers

Take a Bergen County general practice, five operatories, $950,000 in collections, owner producing about 82% of it. Total operating expenses excluding all owner compensation run 62%, so $589,000 out the door and $361,000 of seller's discretionary earnings. On the SDE rule, at 1.65x, that practice prices at $595,650. The revenue cross-check at 0.65x gives $617,500. Those two agree closely, which is the first sign you're looking at the right frame for this size of practice.

Now do the EBITDA conversion the institutional buyer will do. The owner produces $779,000 of the $950,000, and replacing them costs 30% of that production, or $233,700 a year. Subtract that from SDE and the practice has $127,300 of EBITDA. Run it through the sub-$1 million band and you get $636,500 at 5x and $891,100 at 7x.

That top figure is the one every seller fixates on, and it's the one we'd treat with the most suspicion. A 7x multiple inside the sub-$1 million band is reserved for practices at the top of that band, not at $127,300, and no institutional buyer is paying a platform premium for a single-doctor tuck-in. The credible range for this practice is roughly $600,000 to $700,000, and the seller who holds out for $891,100 will spend eighteen months learning that.

Notice what the EBITDA math also tells you about your own job. This owner earns $361,000 as an owner-operator and the business itself earns $127,300. Roughly 65% of what feels like profit is actually wages for chair time. That's not a criticism. It's the thing a buyer is buying, and it's the thing you are selling when you sign.

What Most New Jersey Sellers Get Wrong About Add-Backs

The specific mistake, and it is concentrated among owners in their late fifties and early sixties running one location with one doctor, is treating the add-back schedule as a negotiation instead of a disclosure. The car. The spouse on payroll at $48,000 for bookkeeping that takes six hours a month. The CE trip to Scottsdale. The family cell plan. A seller adds back $95,000 of that, multiplies by 6x, and walks into the room believing the practice is worth $570,000 more than the buyer's model says.

Buyers price add-backs on a sliding scale of credibility. Owner auto and personal travel usually survive. A family salary attached to real work that a $22-an-hour employee would otherwise do gets partially disallowed, because the expense doesn't disappear, it just changes names. Anything without a receipt gets stripped entirely, and once a buyer strips one line they re-underwrite all of them. The seller who pads the schedule doesn't get a higher price. They get a slower deal, a lower price, and a buyer who now discounts the collections report too.

Our view: build the add-back file two years before you list, with documentation for every line, and hand it over unprompted. A $40,000 add-back you can prove is worth more than a $95,000 add-back you have to defend.

4,100 Dentists and the Buyer Pool Problem

New Jersey employed 4,100 general dentists as of May 2023, per the Bureau of Labor Statistics. In one of the densest states in the country, that concentration cuts both ways. In Bergen, Essex, Morris and Middlesex counties, the buyer pool for a healthy $900,000 practice is deep enough that competitive tension is real and a well-prepared seller can run something close to a process. Drive ninety minutes south or west and the pool thins to a handful of local associates and one or two regional groups, which is exactly the situation where the quoted multiple and the closed multiple diverge most.

The structural backdrop matters too. ADA HPI reports 16% of U.S. dentists affiliated with a DSO as of 2024, with private-practice ownership at 72.5% in 2023, down from 84.7% in 2005. The consolidator bid is a permanent feature of this market now, not a cycle. But a permanent bid is not a universal bid, and dense states are precisely where consolidators can be selective.

Dentist ownership structure is shifting toward DSOs

Private-practice ownership, 2005

84.7%

Private-practice ownership, 2023

72.5%

DSO affiliation, 2024

16%

Source: ADA Health Policy Institute

The Six-Dollar Dollar

Here is the part of valuation worth acting on rather than arguing about. At a 6x multiple, one dollar of durable annual EBITDA is worth six dollars of sale price. Cut $38,000 of genuinely fixed annual cost, a renegotiated lease, a supply contract, a software stack nobody uses, and you've added about $228,000 to the enterprise value. Add $100,000 of collections at 38% flow-through and you get the same $228,000. The cost cut is usually faster and always more certain.

Capacity is where the money hides. The Practice Market Index, our own dataset built from 925 dental practice listings, shows practices listed for sale carry a median of 5 operatories (n=754) and median collections per operatory of $200,000, with the middle half between $146,875 and $268,708 (n=643). A five-op practice collecting $750,000 is running $150,000 per chair. Getting two of those chairs to $200,000 is $100,000 of collections against fixed rent and fixed equipment, which is the highest-flow-through growth available to any owner. We'd spend the two years before a sale on chair use and fixed-cost renegotiation, in that order, and ignore the multiple entirely until the last six months.

Where We'd Sell and Where We'd Wait

If you're a solo NJ general practice with under $250,000 of true post-associate EBITDA and you're inside three years of retirement, we'd sell doctor-to-doctor, price off SDE, and stop waiting for a DSO to call. The waiting has a measurable cost: ADA HPI reports practice revenues rose just 1.4% over five years while expenses rose 4.9%, so the practice that's worth $620,000 today is not quietly appreciating while you decide.

Practice expenses are outpacing revenue growth

Revenue growth over five years

1.4%

Expense growth over five years

4.9%

Source: ADA Health Policy Institute

If you're under 55 with four or more operatories and a hygiene department that produces without you, we'd do the opposite and refuse every offer for five years. Getting from $127,300 to $600,000 of EBITDA moves you from the bottom of one band to the middle of the next, and the multiple expansion alone is worth more than the entire practice is worth today. That is the only path we've seen that reliably beats the 20% to 40% institutional premium: stop being the kind of practice that gets a tuck-in price.

What Would Change Our Mind

We're watching two things into 2027. First, whether the institutional premium compresses as debt costs stay elevated, because a narrowing spread between DSO and doctor-to-doctor pricing changes the waiting calculus for every mid-size group in the state. Second, whether sub-$250,000-EBITDA NJ practices start closing above 2.5x SDE with any consistency. If they do, the buyer pool at the small end is deeper than we think and the sell-now advice above gets too conservative. If listing inventory keeps building instead, the discount on single-doctor practices gets wider, not narrower.

Build Your Associate-Replacement P&L This Week

Pull last year's P&L and strip out every dollar of owner compensation, benefit and perk to get your true SDE. Then subtract 30% of your personal production as an associate replacement cost, and whatever's left is the only EBITDA number a buyer will recognize. Put both figures on one page next to your collections per operatory, chair by chair. If the EBITDA line is under $250,000, price your practice off SDE and stop quoting multiples you can't reach.

If you want to see how your own numbers land against the bands above, our valuation calculator runs the SDE and associate-replacement EBITDA math side by side using your collections, overhead and production split. It takes about ten minutes with a P&L in front of you, and it will tell you which band you're actually in before a broker does. Run your own numbers.